Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22296077 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: rhGAD65;   Drug: Placebo
2 Terminated A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: rhGAD65;   Drug: Placebo

Indicates status has not been verified in more than two years